Olga Dashevsky

1.4k total citations
20 papers, 858 citations indexed

About

Olga Dashevsky is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Olga Dashevsky has authored 20 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in Olga Dashevsky's work include Extracellular vesicles in disease (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Immune Cell Function and Interaction (4 papers). Olga Dashevsky is often cited by papers focused on Extracellular vesicles in disease (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Immune Cell Function and Interaction (4 papers). Olga Dashevsky collaborates with scholars based in United States, Israel and Japan. Olga Dashevsky's co-authors include Alexander Brill, David Varon, Yaacov Gozal, Julia Rivo, Ela Shai, Ronen R. Leker, Etty Grad, Haim Danenberg, Constantine S. Mitsiades and Ricardo De Matos Simoes and has published in prestigious journals such as Blood, Cancer Research and International Journal of Cancer.

In The Last Decade

Olga Dashevsky

18 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Dashevsky United States 10 548 224 205 194 120 20 858
Anna Zetser Israel 11 1.3k 2.3× 198 0.9× 146 0.7× 220 1.1× 43 0.4× 14 1.7k
Marie-Luise von Brühl Germany 8 253 0.5× 117 0.5× 136 0.7× 54 0.3× 300 2.5× 12 842
Xiaohe Cai United States 14 356 0.6× 141 0.6× 61 0.3× 186 1.0× 118 1.0× 24 1000
Zhangsen Huang China 11 188 0.3× 151 0.7× 189 0.9× 51 0.3× 121 1.0× 20 582
Ariane Galaup France 15 667 1.2× 108 0.5× 148 0.7× 372 1.9× 139 1.2× 17 1.3k
Kalpana Nattamai United States 14 740 1.4× 371 1.7× 200 1.0× 93 0.5× 259 2.2× 26 1.3k
Claire Peghaire France 13 356 0.6× 104 0.5× 55 0.3× 72 0.4× 74 0.6× 16 642
Rachel Krasich United States 5 941 1.7× 111 0.5× 223 1.1× 202 1.0× 111 0.9× 5 1.2k
W. Ito Germany 7 790 1.4× 57 0.3× 109 0.5× 157 0.8× 158 1.3× 12 1.1k
Jian Qi China 12 505 0.9× 86 0.4× 193 0.9× 388 2.0× 103 0.9× 30 1.1k

Countries citing papers authored by Olga Dashevsky

Since Specialization
Citations

This map shows the geographic impact of Olga Dashevsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Dashevsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Dashevsky more than expected).

Fields of papers citing papers by Olga Dashevsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Dashevsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Dashevsky. The network helps show where Olga Dashevsky may publish in the future.

Co-authorship network of co-authors of Olga Dashevsky

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Dashevsky. A scholar is included among the top collaborators of Olga Dashevsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Dashevsky. Olga Dashevsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morimoto, Yoshihiro, Nami Yamashita, Naoki Haratake, et al.. (2023). MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells. Journal for ImmunoTherapy of Cancer. 11(2). e006238–e006238. 16 indexed citations
2.
Dashevsky, Olga, Ricardo De Matos Simoes, Benjamin G. Barwick, et al.. (2021). Functional Genomic and Immune Response Characterization of PTEN Loss: Therapeutic Implications for Myeloma. Blood. 138(Supplement 1). 1612–1612.
3.
Gandolfi, Sara, Olli Dufva, Jani Huuhtanen, et al.. (2021). Functional Genomic Landscape of Natural Killer Cell Evasion in Multiple Myeloma. Blood. 138(Supplement 1). 732–732. 2 indexed citations
4.
Gandolfi, Sara, Olli Dufva, Jani Huuhtanen, et al.. (2021). OAB-019: CRISPR screens with single-cell transcriptome readout reveal potential mechanisms of response to natural killer cell treatment in multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 21. S12–S13. 1 indexed citations
5.
Dashevsky, Olga, Ricardo De Matos Simoes, Ryosuke Shirasaki, et al.. (2020). Use of Olfactory Receptor Genes As Controls for Genome-Scale CRISPR Functional Genomic Studies to Define Treatment Resistance Mechanisms. Blood. 136(Supplement 1). 36–36.
6.
Gandolfi, Sara, Michal Sheffer, Olga Dashevsky, et al.. (2019). Molecular markers of MM cell sensitivity and resistance to Natural Killer cells: implications for anti-MM immunotherapy. Clinical Lymphoma Myeloma & Leukemia. 19(10). e168–e169. 1 indexed citations
7.
Tang, Huihui, Ricardo De Matos Simoes, Ryosuke Shirasaki, et al.. (2018). CRISPR Activation Screen for HDAC Inhibitor Resistance. Blood. 132(Supplement 1). 3958–3958. 1 indexed citations
8.
Shirasaki, Ryosuke, Sara Gandolfi, Ricardo De Matos Simoes, et al.. (2018). Abstract 2834: Genomewide CRISPR studies of sequential treatment with CRBN-based degronimids: Insights into the molecular evolution of treatment resistance in myeloma and beyond. Cancer Research. 78(13_Supplement). 2834–2834. 1 indexed citations
9.
Simoes, Ricardo De Matos, Ryosuke Shirasaki, Huihui Tang, et al.. (2018). Functional Genomic Landscape of Genes with Recurrent Mutations in Multiple Myeloma. Blood. 132(Supplement 1). 189–189. 2 indexed citations
10.
Gandolfi, Sara, Olga Dashevsky, Ricardo De Matos Simoes, et al.. (2017). Long-Term Interactions with Bone Marrow Stromal Cells Alter the Molecular Dependencies of Myeloma Cells: Insights from Genomewide CRISPR-Based Functional Genomic Screens. Blood. 130. 3028–3028. 1 indexed citations
11.
Matthews, Geoffrey M., Ricardo De Matos Simoes, Eugen Dhimolea, et al.. (2016). NF-κB dysregulation in multiple myeloma. Seminars in Cancer Biology. 39. 68–76. 43 indexed citations
12.
Dashevsky, Olga, et al.. (2013). Platelet lysates stimulate angiogenesis, neurogenesis and neuroprotection after stroke. Thrombosis and Haemostasis. 110(8). 323–330. 57 indexed citations
13.
Dashevsky, Olga, et al.. (2012). Platelet Microparticles Induce Angiogenesis and Neurogenesis after Cerebral Ischemia. Current Neurovascular Research. 9(3). 185–192. 94 indexed citations
14.
Dashevsky, Olga, et al.. (2012). Platelet Microparticles Promote Neural Stem Cell Proliferation, Survival and Differentiation. Journal of Molecular Neuroscience. 47(3). 659–665. 63 indexed citations
15.
Varon, David, et al.. (2012). Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration. Thrombosis Research. 130. S98–S99. 50 indexed citations
16.
Dashevsky, Olga, Ela Shai, & David Varon. (2011). Platelet Microparticles Increase Pro-Angiogenic Properties of Prostate Cancer Cell Lines. Blood. 118(21). 1147–1147. 2 indexed citations
17.
Sela, Uri, Alexander Brill, Vyacheslav Kalchenko, Olga Dashevsky, & Rami Hershkoviz. (2008). Allicin Inhibits Blood Vessel Growth and Downregulates Akt Phosphorylation and Actin Polymerization. Nutrition and Cancer. 60(3). 412–420. 23 indexed citations
18.
Dashevsky, Olga, David Varon, & Alexander Brill. (2008). Platelet‐derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP‐2 production. International Journal of Cancer. 124(8). 1773–1777. 107 indexed citations
19.
Brill, Alexander, et al.. (2006). C‐reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis. British Journal of Haematology. 134(4). 426–431. 46 indexed citations
20.
Brill, Alexander, et al.. (2005). Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovascular Research. 67(1). 30–38. 348 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Zetser Breakdown of academic impact, for papers by Marie-Luise von Brühl Breakdown of academic impact, for papers by Xiaohe Cai Breakdown of academic impact, for papers by Zhangsen Huang Breakdown of academic impact, for papers by Ariane Galaup Breakdown of academic impact, for papers by Kalpana Nattamai Breakdown of academic impact, for papers by Claire Peghaire Breakdown of academic impact, for papers by Rachel Krasich Breakdown of academic impact, for papers by W. Ito Breakdown of academic impact, for papers by Jian Qi
Rankless by CCL
2026